AIM at Melanoma

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through groundbreaking research, legislative reform, education, and patient and caregiver support.

Latest from AIM at Melanoma


In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses

February 23, 2021

Intratumoral injection—the boosting of the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses—is a promising treatment method because it’s effective AND it seems to cause fewer toxicities for the patient than combination systemic immunotherapy.

Savoring Every Ounce of Life While Undergoing Treatment for Skin Cancer

January 14, 2021

In this episode of the “CURE Talks Cancer” podcast, we spoke with someone who has undergone 41 surgeries and physically debilitating treatments during his more than 15-year journey with several cases of skin cancer. We discussed his cancer journey, and why, as he starts a new treatment after his most prior therapy failed, he’s focused on quality rather than quantity of life.